GLP-1 Medications and Cancer Risk, Part 2
Video: Dr. Johnston reviews a 1.65 million-patient study linking GLP-1 drugs to lower risk of 10 obesity-related cancers.
14 matches across articles, videos and resources.
Video: Dr. Johnston reviews a 1.65 million-patient study linking GLP-1 drugs to lower risk of 10 obesity-related cancers.
Video: Dr. Johnston reviews a 2025 observational study of 86,000 adults comparing cancer rates in people taking GLP-1 drugs with those who were not.
ArticleDr. Johnston looks at studies linking obesity to cancer and examines whether GLP-1 medications are associated with lower cancer risk, noting that the evidence is observational.
ArticleThe ALASCCA trial found low-dose aspirin cut colorectal cancer recurrence in tumors with PI3K pathway changes. Here is what it shows and the bleeding risks.
Video: the ALASCCA trial found low-dose aspirin lowered 3-year colorectal cancer recurrence in tumors with PIK3CA changes. Includes the bleeding risks.
ArticleLab studies explore how methylene blue interacts with light and cancer cell energy use. Human evidence is thin, and the drug-interaction risks are serious.
Video: PSK, a Turkey Tail extract used in Japan, was tested in randomized cancer trials. The survival signal is modest and low certainty. Tea is not PSK.
Video: a 2000 case-control study on sunscreen use and melanoma, and a 2023 meta-analysis of vitamin D3 and cancer mortality. Part 1 of 2.
Video: Dr. Johnston reviews a 2025 analysis of 21 prospective studies on blood lycopene levels and cancer deaths, lung and breast cancer, plus lab findings.
Video: a large analysis linked statins to lower cancer mortality, but observational data cannot prove cause and effect. What the evidence shows.
Video: analyses of randomized trials in advanced lung cancer compared chemotherapy alone with chemotherapy plus astragalus-based herbal medicine.
ArticleDr. Johnston ranks the ten supplements and repurposed generic drugs he would put on his own shortlist, weighing human trials first, then animal and laboratory research.
ArticleDr. Johnston asks whether MTHFR variants matter more under stress such as COVID-19, and why he turned to L-methylfolate.
Video: how L-methylfolate differs from folic acid, why common MTHFR gene variants may matter, and what a small phase I glioma trial found. Educational only.